Alternatives
Alternatives to Infliximab 100 mg/10 mL powder for injection
There are 3 alternatives to this medicine in the catalogue: the same active ingredient (Infliximab), strength (100 mg/10 mL) and dosage form (powder for injection) from 3 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Infliximab 100 mg/10 mL powder for injectionThis pageIntravenous | — | US FDA | 1 vial | Cold chain | On request | — | Available on request |
| Avsola 100 mg/10 mL powder for injectionIntravenous | Amgen | US FDA | 1 vial, 1 vial | Cold chain | On request | — | Available on request |
| Inflectra 100 mg/10 mL powder for injectionIntravenous | Pfizer Laboratories | US FDA | 1 vial | Cold chain | On request | — | Available on request |
| Remicade 100 mg/10 mL powder for injectionIntravenous | Janssen Biotech | US FDA | 1 vial | Cold chain | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Infliximab 100 mg/10 mL powder for injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.